HB 1670 Board of Pharmacy; pharmaceutical processors; cannabis oil.

Introduced by: Israel D. O'Quinn | all patrons ... notes | add to my profiles SUMMARY AS INTRODUCED: Board of Pharmacy; pharmaceutical processors; cannabis oil. Replaces the definitions of cannabidiol oil and THC-A oil with a definition for cannabis oil. The bill allows pharmaceutical processors to acquire industrial hemp grown and processed in Virginia from a registered industrial hemp dealer or processor and allows a pharmaceutical processor to process and formulate industrial hemp with cannabis plant extract into an allowable dosage.

By |2020-01-17T12:28:24-05:00January 17th, 2020|Health Care, Rx|Comments Off on HB 1670 Board of Pharmacy; pharmaceutical processors; cannabis oil.

HB 1659 Health insurance; carrier contracts with pharmacy benefits managers.

Introduced by: Christopher T. Head | all patrons ... notes | add to my profiles SUMMARY AS INTRODUCED: Health insurance; carrier contracts with pharmacy benefits managers. Prohibits a health insurance carrier from entering into, amending, renewing, or extending a contract with a pharmacy benefits manager unless such contract contains provisions prohibiting the pharmacy benefits manager or his representative from reimbursing a pharmacy or pharmacist an amount less than the amount that the pharmacy benefits manager reimburses a pharmacy benefits manager affiliate for providing the same pharmacist services, calculated on a per-unit basis using the same product identifier or code number and reflecting all drug manufacturer's rebates, direct and indirect administrative fees, and costs and any remuneration. The bill applies to contracts entered into, amended, renewed, or extended on and after July 1, 2021.

By |2020-01-17T12:29:25-05:00January 17th, 2020|Health Care, Rx|Comments Off on HB 1659 Health insurance; carrier contracts with pharmacy benefits managers.

SB 976 Board of Pharmacy; pharmaceutical processors; processing and dispensing cannabis oil.

Introduced by: David W. Marsden | all patrons ... notes | add to my profiles SUMMARY AS INTRODUCED: Board of Pharmacy; pharmaceutical processors; processing and dispensing cannabis oil. Replaces the definitions of cannabidiol oil and THC-A oil with a definition for cannabis oil. The bill requires the Board of Pharmacy to establish a pharmacist-to-pharmacist-technician supervision ratio of one to eight for pharmaceutical processors. The bill allows practitioners to utilize telemedicine in evaluating and treating patients related to the issuance of written certifications for the use of cannabis oil. The bill permits pharmaceutical processors to establish up to five off-site dispensing locations

By |2020-01-17T12:33:29-05:00January 15th, 2020|Health Care, Rx|Comments Off on SB 976 Board of Pharmacy; pharmaceutical processors; processing and dispensing cannabis oil.

SB 969 Pharmaceutical processors; off-site dispensing locations.

Introduced by: David W. Marsden | all patrons ... notes | add to my profiles SUMMARY AS INTRODUCED: Pharmaceutical processors; off-site dispensing locations. Allows each pharmaceutical processor to whom a permit has been issued by the Board of Pharmacy to operate up to five off-site dispensing locations for the dispensing of cannabidiol oil and THC-A oil.

By |2020-01-17T12:33:53-05:00January 14th, 2020|Health Care, Rx|Comments Off on SB 969 Pharmaceutical processors; off-site dispensing locations.

HB 1559 Prescription drug price transparency; penalties.

Introduced by: Chris L. Hurst | all patrons ... notes | add to my profiles SUMMARY AS INTRODUCED: Prescription drug price transparency; penalties. Requires pharmaceutical drug manufacturers, pharmacy benefits managers, and health carriers to submit reports containing certain information concerning prescription drug costs to the Commissioner of the Bureau of Insurance (the Commissioner). The measure requires pharmaceutical drug manufacturers' reports to include information on the current wholesale acquisition cost information for FDA-approved drugs sold in or into the Commonwealth by the pharmaceutical drug manufacturer. The bill also requires such manufacturers to submit a report for drugs with a wholesale acquisition cost of at least $50 for a 30-day supply when their wholesale acquisition cost increases by

By |2020-01-17T12:37:07-05:00January 14th, 2020|Health Care, Rx|Comments Off on HB 1559 Prescription drug price transparency; penalties.

HB 1506 Pharmacists; prescribing, dispensing, and administration of controlled substances.

Introduced by: Mark D. Sickles | all patrons ... notes | add to my profiles SUMMARY AS INTRODUCED: Pharmacists; prescribing, dispensing, and administration of controlled substances. Authorizes the prescribing, dispensing, and administration of certain controlled substances by a pharmacist, provided that such pharmacist prescribes, dispenses, or administers such controlled substances in accordance with a statewide protocol developed by the Board of Pharmacy in consultation with the Board of Medicine and set forth in regulations of the Board of Pharmacy. The bill clarifies that an accident and sickness insurance policy that provides reimbursement for a service that may be legally performed by a licensed pharmacist shall provide reimbursement for the prescribing, dispensing, or administration of controlled substances by a pharmacist when

By |2020-01-17T13:11:05-05:00January 12th, 2020|Health Care, Rx|Comments Off on HB 1506 Pharmacists; prescribing, dispensing, and administration of controlled substances.

HB 1498 Pharmaceutical Manufacturing Grant Program and Fund; created.

Introduced by: Mark D. Sickles | all patrons ... notes | add to my profiles SUMMARY AS INTRODUCED: Pharmaceutical Manufacturing Grant Program; creation. Creates the Pharmaceutical Manufacturing Grant Program to make grant payments to an eligible pharmaceutical manufacturer that makes a capital investment of at least $1 billion at a facility in Rockingham County and creates at least 152 new full-time jobs at the facility. The pharmaceutical manufacturer would be eligible for an aggregate of $7.5 million in grants paid out over a three-year period if it meets such performance parameters. The bill also makes available, subject to appropriation, $2.525 million to a comprehensive community college and baccalaureate

By |2020-01-17T13:11:57-05:00January 12th, 2020|Health Care, Rx|Comments Off on HB 1498 Pharmaceutical Manufacturing Grant Program and Fund; created.

HB 1479 Pharmacy benefits managers.

Introduced by: Ibraheem S. Samirah | all patrons ... notes | add to my profiles SUMMARY AS INTRODUCED: Pharmacy benefits managers. Requires pharmacy benefits managers to register with the Commissioner of the Bureau of Insurance. The measure prohibits a carrier on its own or through its contracted pharmacy benefits manager or representative of a pharmacy benefits manager from (i) causing or knowingly permitting the use of any advertisement, promotion, solicitation, representation, proposal, or offer that is untrue, deceptive, or misleading; (ii) charge a pharmacist or pharmacy a fee related to the adjudication of a claim; (iii) engaging, with the express intent or purpose of driving out competition or financially injuring competitors, in a pattern or practice of reimbursing retail community pharmacies or pharmacists in the Commonwealth consistently less than the amount that the pharmacy benefits manager reimburses a pharmacy benefits manager affiliate for providing the same pharmacist

By |2020-01-17T13:12:46-05:00January 12th, 2020|Health Care, Rx|Comments Off on HB 1479 Pharmacy benefits managers.

HB 1459 Pharmacy benefits managers.

Introduced by: Israel D. O'Quinn | all patrons ... notes | add to my profiles SUMMARY AS INTRODUCED: Pharmacy benefits managers. Requires pharmacy benefits managers to register with the Commissioner of the Bureau of Insurance. The measure prohibits a carrier on its own or through its contracted pharmacy benefits manager or representative of a pharmacy benefits manager from (i) causing or knowingly permitting the use of any advertisement, promotion, solicitation, representation, proposal, or offer that is untrue, deceptive, or misleading; (ii) charge a pharmacist or pharmacy a fee related to the adjudication of a claim; (iii) engaging, with the express intent or purpose of driving out competition or financially injuring competitors, in a pattern or practice of reimbursing retail community pharmacies or pharmacists in the Commonwealth consistently less than the amount that the pharmacy benefits manager reimburses a pharmacy benefits manager affiliate for providing the same pharmacist services; (iv) collecting or requiring a pharmacy or pharmacist to collect from an insured a copayment for a prescription drug at the point of sale in an amount that exceeds the lesser of the contracted copayment amount, the amount an individual would pay for a prescription drug if that individual was paying cash, or the contracted amount for the drug; (v) reimbursing a pharmacy or pharmacist an amount less

By |2020-01-17T13:13:06-05:00January 12th, 2020|Health Care, Rx|Comments Off on HB 1459 Pharmacy benefits managers.

HB 1456 Medical assistance services; managed care organization contracts with pharmacy providers.

Introduced by: Ibraheem S. Samirah | all patrons ... notes | add to my profiles SUMMARY AS INTRODUCED: Medical assistance services; managed care organization contracts with pharmacy providers; recoupment of direct and indirect remuneration fees. Requires the Department of Medical Assistance Services to require a managed care organization with which the Department enters into an agreement for the delivery of medical assistance services to include in any agreement between the managed care organization and an intermediary a provision prohibiting the intermediary from recouping direct and indirect remuneration fees with respect to a prescription.

By |2020-01-17T13:13:59-05:00January 12th, 2020|Health Care, Rx|Comments Off on HB 1456 Medical assistance services; managed care organization contracts with pharmacy providers.